Healx, a Cambridge, England-based AI-powered and patient-inspired technology company specializing in treatments for rare diseases, today announces that it has raised $56M in a Series B financing round, led by one of Europe’s largest VC firms Atomico and joined by Intel Capital, Global Brain, and btov Partners. All previous investors, including Balderton Capital, Amadeus Capital Partners, and Jonathan Milner also participated in the round.
Date : October 16, 2019 at 11:38PM
Tag(s) : #eSANTE ENG
